ANVISA Nutraceutical Dietary Supplements Regulations in Brazil
With the increasing health consciousness among the Brazilian population of 215 million, there has been increasing demand for nutraceuticals and […]
With the increasing health consciousness among the Brazilian population of 215 million, there has been increasing demand for nutraceuticals and […]
Brazil is the largest pharmaceutical market in South America with a CAGR of 10.6%. With the rise in globalization, pharmaceutical
Brazilian Health Regulatory Agency (ANVISA) is responsible for cosmetic regulations in Brazil. Under the Directorate of Coordination of the National
The Brazilian health authority ANVISA (Agência Nacional de Vigilância Sanitária) has recently updated the drug registration process in Brazil. The
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales